PRRT2 and Hyperglycemia: Several hyperglycemia-associated mechanisms have been identified that contribute to the development of DM complications, including ROS, excessive polyol flux, higher Advanced Glycation End (AGE) product formation, and overactivation of protein kinase C (PKC) pathways [34].